Glenmark Pharmaceuticals Fundamentals
P/E Ratio
45.61
P/B Ratio
6.22
Div. Yield
0.11
Sector P/E
69.94
Sector P/B
2.97
Sec. Div. Yield
0.55
Glenmark Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 45.61, compared to the sector average of 69.94. Its P/B Ratio stands at 6.22, while the sector’s is 2.97. In terms of returns, the stock offers a Dividend Yield of 0.11%, which is than the sector’s 0.55%.
Glenmark Pharmaceuticals Score Card
Price
Attractive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Glenmark Pharmaceuticals reflects: Price – Attractive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals Share Price
- Glenmark Pharmaceuticals Share Price chart
- Glenmark Pharmaceuticals Technical Analysis
- Glenmark Pharmaceuticals Peer Comparison
- Glenmark Pharmaceuticals Share Price History
- Glenmark Pharmaceuticals Dividend
- Glenmark Pharmaceuticals Board of Directors
- Glenmark Pharmaceuticals Shareholding Pattern
